Resources

Type of publications
Regions
Diseases

5255 results found

2025 ∙ Chiavarini, M. Genga, A. Ricciotti, G. M. D'Errico, M. M. Barbadoro, P.

Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials

  • All age groups
  • Cytomegalovirus
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Al-omoush, O. Khalil, L. Ramadan, A. Tarakhan, H. Alzoubi, A. Nabil, A. Hajali, M. Abdelazeem, B. Saleh, O.

Sarcoidosis and COVID-19 Vaccines: A Systematic Review of Case Reports and Case Series

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Bylica, I. Jachowicz-Matczak, E. Brodowicz, J. Su Bociąga-Jasik, M. Heczko, P. Gagatek, S. Bylica, J. W

SARS-CoV-2 Vaccine-Induced Humoral Immunity in Immunocompetent European Adults: A Systematic Review

  • Europe
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Zeleke, A. M. Tassew, W. C. Bayeh, G. M. Ayale Ferede, Y.

Satisfaction with maternal health services and associated factors among parents in Ethiopia: a systematic review and meta-analysis

  • Africa
  • Ethiopia
  • Parents/caregivers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ma, R. Du, Y. Jing, W. Ma, H. Wang, K. Liu, A. Chen, S. Zhou, M. Zhou, Y. Su, S. Zhang, L. Yang, Y.

Seasonal influenza vaccination rate and vaccine effectiveness among older adults in mainland China: A systematic review and meta-analysis

  • Western Pacific
  • China
  • Adults
  • Older adults
  • Influenza
  • Coverage
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ma, K. S. K. Shen, C. H. Chiang, M. H. Blumenthal, K. G. Chen, S. T.

Severe Cutaneous Adverse Reactions Following Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Wan, S. Zhang, S. Hu, S. Luo, C. Liu, G. Ramos da Conceicao, L. D. Costa Encarnacao, M. D. Zhao, L. Y.

Should routine HPV vaccination programs include males 25-29 years? A systematic review and global meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Kumar, P. Ray, A. Hora, R. Kumari, A. Singh, K. Mehra, R. Kaur, A. Singh, S. K. Singh Koshal, S. Kumar Singh, V. Sultana, A. Quadri, S. F. Deb Roy, A.

Social Determinants of Human Papillomavirus Vaccine Uptake Among Adolescent Girls in Low-Middle-Income Countries: A Systematic Review & Meta-Analysis

  • Adolescents
  • Adults
  • Low and Middle Income Countries
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Almeida-Silva, M. Vieira, L. Grilo, A. Pedro, L. Coelho, A. Carolino, E. Umanets, O. Andrade, G.

Socio-Demographic and Psychological Determinants of COVID-19 Vaccination Intention in Europe and North America: A Systematic Review

  • Europe
  • Americas
  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Okoli, G. N. Soos, A. E. Etsell, K. Grossman Moon, A. Kimmel Supron, H. Grewal, A. Neilson, C. J. Richardson, C. Harper, D. M.

Socioeconomic and Health-Related Characteristics Associated with Initiation and Completion of Human Papillomavirus Vaccination among Males in the United States: An In-Depth Systematic Review and Meta-Analysis

  • Americas
  • United States of America
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...